Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion - PubMed (original) (raw)
Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion
Lisa B E Shields et al. Spine (Phila Pa 1976). 2006.
Abstract
Study design: A retrospective review of patients who underwent an anterior cervical fusion using recombinant human bone morphogenetic protein (rhBMP)-2 with an absorbable collagen sponge (INFUSE; Medtronic Sofamor Danek, Minneapolis, MN).
Objective: To ascertain the complication rate after the use of high-dose INFUSE in anterior cervical fusions.
Summary of background data: The rhBMP-2 has been primarily investigated in lumbar spine fusions, where it has significantly enhanced the fusion rate and decreased the length of surgery, blood loss, and hospital stay.
Methods: We present 151 patients who underwent either an anterior cervical discectomy and fusion (n = 138) or anterior cervical vertebrectomy and fusion (n = 13) augmented with high-dose INFUSE between July 2003 and March 2004. The rhBMP-2 (up to 2.1 mg/level) was used in the anterior cervical discectomy and fusions.
Results: A total of 35 (23.2%) patients had complications after the use of high-dose INFUSE in the cervical spine. There were 15 patients diagnosed with a hematoma, including 11 on postoperative day 4 or 5, of whom 8 were surgically evacuated. Thirteen individuals had either a prolonged hospital stay (> 48 hours) or hospital readmission because of swallowing/breathing difficulties or dramatic swelling without hematoma.
Conclusions: A significant rate of complications resulted after the use of a high dose of INFUSE in anterior cervical fusions. We hypothesize that in the cervical area, the putative inflammatory effect that contributes to the effectiveness of INFUSE in inducing fusion may spread to adjacent critical structures and lead to increased postoperative morbidity. A thorough investigation is warranted to determine the optimal dose of rhBMP-2 that will promote cervical fusion and minimize complications.
Comment in
- Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".
Bennett M, Reynolds AS, Dickerman RD. Bennett M, et al. Spine (Phila Pa 1976). 2006 Aug 1;31(17):2029-30. doi: 10.1097/01.brs.0000229387.20297.b1. Spine (Phila Pa 1976). 2006. PMID: 16924224 No abstract available.
Similar articles
- Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH 3rd, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD. Crawford CH 3rd, et al. Spine (Phila Pa 1976). 2009 Jun 1;34(13):1390-4. doi: 10.1097/BRS.0b013e3181a2da08. Spine (Phila Pa 1976). 2009. PMID: 19440166 - Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK, Steinmetz MP, Krishnaney AA. Hiremath GK, et al. Spine (Phila Pa 1976). 2009 Apr 20;34(9):885-9. doi: 10.1097/BRS.0b013e31819e334a. Spine (Phila Pa 1976). 2009. PMID: 19531997 - Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR. Glassman SD, et al. Spine J. 2007 Jan-Feb;7(1):44-9. doi: 10.1016/j.spinee.2006.06.381. Epub 2006 Nov 20. Spine J. 2007. PMID: 17197332 - Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma.
Shahlaie K, Kim KD. Shahlaie K, et al. Spine (Phila Pa 1976). 2008 Oct 1;33(21):2361-6. doi: 10.1097/BRS.0b013e318183971d. Spine (Phila Pa 1976). 2008. PMID: 18827703 Review. - Anterior cervical discectomy and fusion without instrumentation.
Wright IP, Eisenstein SM. Wright IP, et al. Spine (Phila Pa 1976). 2007 Apr 1;32(7):772-4; discussion 775. doi: 10.1097/01.brs.0000258846.86537.ad. Spine (Phila Pa 1976). 2007. PMID: 17414911 Review.
Cited by
- Biologic adjuvants for fracture healing.
Virk MS, Lieberman JR. Virk MS, et al. Arthritis Res Ther. 2012 Nov 30;14(6):225. doi: 10.1186/ar4053. Arthritis Res Ther. 2012. PMID: 23198865 Free PMC article. Review. - Multilevel Corpectomy for Subaxial Cervical Spondylodiscitis: Literature Review and Role of Navigation, Intraoperative Imaging and Augmented Reality.
Umana GE, Scalia G, Spitaleri A, Passanisi M, Crea A, Tomasi OS, Cicero S, Maugeri R, Iacopino DG, Visocchi M. Umana GE, et al. Acta Neurochir Suppl. 2023;135:331-338. doi: 10.1007/978-3-031-36084-8_50. Acta Neurochir Suppl. 2023. PMID: 38153489 - Effect of grafting BMP2-derived peptide to nanoparticles on osteogenic and vasculogenic expression of stromal cells.
Mercado AE, Yang X, He X, Jabbari E. Mercado AE, et al. J Tissue Eng Regen Med. 2014 Jan;8(1):15-28. doi: 10.1002/term.1487. Epub 2012 Jul 5. J Tissue Eng Regen Med. 2014. PMID: 22764116 Free PMC article. - Soft Tissue Swelling Associated with the Use of Recombinant Human Bone Morphogenetic Protein-2 in Long Bone Non-unions.
Young A, Mirarchi A. Young A, et al. J Orthop Case Rep. 2015 Jul-Sep;5(3):18-21. doi: 10.13107/jocr.2250-0685.297. J Orthop Case Rep. 2015. PMID: 27299059 Free PMC article. - Exploratory meta-analysis on dose-related efficacy and complications of rhBMP-2 in anterior cervical discectomy and fusion: 1,539,021 cases from 2003 to 2017 studies.
Wen YD, Jiang WM, Yang HL, Shi JH. Wen YD, et al. J Orthop Translat. 2020 Feb 18;24:166-174. doi: 10.1016/j.jot.2020.01.002. eCollection 2020 Sep. J Orthop Translat. 2020. PMID: 33101967 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials